Scientific Sessions 2014
 
Session Archives
 

2015 ♦ 2014  201320122011

2015 ♦ 2014 ♦ 20132012




2015 ♦ 2014 ♦ 20132012 ♦ 2011

2015 ♦ 2014  20132012 ♦ 2011




2015 ♦ 2014 ♦ 20132012 ♦ 2011 




2015 ♦ 2014 ♦ 20132012 ♦ 2011

2015 ♦ 2014 ♦ 20132012 ♦ 2011


Additional Meetings
ACC:
2012 ♦ 2011
 

ESC Congress: 
2014 
♦ 2012 ♦ 2011
WCC:
2012
 

Scientific Sessions Information & Science News

Through a $75 million investment over at least five years, the American Heart Association (AHA), Verily and AstraZeneca are embarking on a groundbreaking research enterprise to prevent and/or reverse coronary heart disease and its consequences. This is the single largest research project funding one leader and team in the fight to cure coronary ... more...
The 2016 Update of Heart Disease and Stroke Statistics includes: Updated mortality trends for heart disease, stroke and other CV conditions New incidence data for coronary heart disease, heart attack and heart failure Updated incidence and survival rates for cardiac arrest New information on stroke in young adults New emphasis on ... more...
Fausto Pinto, MD, president of the European Society of Cardiology, Mariell Jessup, MD, past president of the American Heart Association, and Margaret Redfield, MD investigator for NEAT-HFpEF, provide expert commentary for the heart failure science presented in LBCT.01 Failure Is Not An Option: New Drugs and Systems of Care. more...
Posted by Kerstin Wiggins on AHA Scientific Sessions Nov 9, 2015 7:47 AM CST
Miss a Session?  Sessions OnDemand™ Premium  is a digital video library of this year's meeting online and on a USB drive.   more...
Posted by Kerstin Wiggins on AHA Scientific Sessions Nov 8, 2015 1:24 PM CST
 All Scientific Sessions 2015 abstracts are now posted on the Circulation website. more...
Posted by Kerstin Wiggins on AHA Scientific Sessions Nov 8, 2015 11:35 AM CST
  more...
Posted by Kerstin Wiggins on AHA Scientific Sessions Nov 5, 2015 10:10 PM CST
  Acquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape A Conference Report From the American Heart Association Data Summit 2015 The AHA Data Summit was a 1.5-day interactive forum convened to discuss critical issues in the acquisition, analysis, and sharing of data in the field of cardiovascular and stroke science. Summit participants represented stakeholders from 7 domains (patients, basic scientists, clinical investigators, population researchers, clinicians and healthcare system administrators, industry, and regulatory authorities) and discussed data as viewed from conventional medical and nonmedical sources, building and using Big Data repositories, articulation of the goals of data sharing, and principles of responsible data sharing. Potential roles that the AHA might consider in the Big Data environment include facilitating a standards discussion, providing education, and helping build an interoperable digital ecosystem in cardiovascular and stroke science. Read the full article in  JAHA more...
  American Heart Association and American Thoracic Society Joint Guidelines for Pediatric Pulmonary Hypertension Pulmonary hypertension is associated with diverse cardiac, pulmonary and systemic diseases in neonates, infants and older children and contributes to significant morbidity and mortality. Many gaps remain regarding our knowledge of the developing lung circulation and its response to injury, unique features of PH in children, and optimal clinical evaluations and treatment strategies. These joint guidelines represent consensus from experts in the field addressing current approaches to care. Read the full article in  Circulation more...
Learn more about the NEW programming track, Frontiers in Science, at Scientific Sessions 2015 in Orlando from Aruna Pradhan, MD, MPH, MSc. Register for #AHA15 today at scientificsessions.org! more...
Posted by Kerstin Wiggins on AHA Scientific Sessions Nov 3, 2015 3:16 PM CST
Mark Creager, MD, president of the American Heart Association, interviews program co-chairs Frank Sellke, MD and Eric Peterson, MD about some of the highlights planned for Scientific Sessions 2015 in Orlando. more...
Posted by Kerstin Wiggins on AHA Scientific Sessions Nov 2, 2015 4:03 PM CST
  Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities The recommendations address organized and sanctioned competitive sports participation. Young trained athletes with underlying cardiovascular abnormalities are at an increased risk for sudden cardiac death. Considerations such as protection of the athlete’s health and avoidance of an unreasonable risks for sudden death during competitive athletics are stressed when addressing medical eligibility versus disqualification decisions, which have become increasingly complex. Read the full Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities articles in  Circulation Preamble , Principles, and General Considerations Task Force 1 : Classification of Sports: Dynamic, Static and Impact Task Force 2 : Preparticipation Screening for Cardiovascular Disease in Competitive Athletes Task Force 3 : Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis Task Force 4 : Congenital Heart Disease Task Force 5 : Valvular Heart Disease Task Force 6 : Hypertension Task Force 7 : Aortic Diseases, Including Marfan Syndrome Task Force 8 : Coronary Artery Disease Task Force 9 : Arrhythmias and Conduction Defects Task Force 10 : The Cardiac Channelopathies Task Force 11 : Drugs and Performance Enhancing Substances Task Force 12 : Emergency Action Plans, Resuscitation, CPR, and AEDs Task Force 13 : Commotio Cordis Task Force 14 : Sickle Cell Trait Task Force 15 : Legal Aspects of Medical Eligibility and Disqualification Recommendations more...
With Scientific Sessions 2015 approaching, have you plotted out which sessions you would like to attend?   more...
Posted by Kerstin Wiggins on AHA Scientific Sessions Oct 30, 2015 3:32 PM CDT